IL6 and breast cancer: In contrast, in studies of taxane-based chemotherapy in 30 women with advanced breast cancer, increased NK and LAK cell activity and increased IL-6, GM-CSF, and IFNγ levels with decreased IL-1 and TNFα levels were reported in cancer patients following chemotherapy, and correlated with clinical responses [48].